Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a liver drug help hepatitis c patients?

NCT ID NCT00200343

First seen Jan 10, 2026 · Last updated Apr 30, 2026 · Updated 13 times

Summary

This study tested whether ursodeoxycholic acid (UDCA) can improve liver health in people with chronic hepatitis C. About 600 adults in Japan took different doses of UDCA for 24 weeks. Researchers measured changes in liver enzymes to see if higher doses work better than a low dose.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS C are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Department of Gastroenterology, University of Tokyo

    Hongo, Bunkyo-ku, Tokyo, Japan

Conditions

Explore the condition pages connected to this study.